Narrow-moat Carl Zeiss Meditec reported soft fourth-quarter earnings that came in lower than our expectations and ended the year on a soft note. Total sales of EUR 580 million during the quarter ...

Here is another substantial technology contribution from Carl Zeiss to the battle against infectious diseases: Primo Star iLED, the new tuberculosis test microscope. Primo Star iLED is the ...

There's been a notable change in appetite for Carl Zeiss Meditec AG (ETR:AFX) shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approximately ...